These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36641673)

  • 1. Insomnia Symptoms and Biomarkers of Alzheimer's Disease in the Community.
    Nicolazzo J; Cavuoto M; Rowsthorn E; Cribb L; Bransby L; Gibson M; Wall P; Velakoulis D; Eratne D; Buckley R; Yassi N; Yiallourou S; Brodtmann A; Hamilton GS; Naughton MT; Lim YY; Pase MP
    J Alzheimers Dis; 2023; 91(4):1423-1434. PubMed ID: 36641673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
    J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults.
    Sprecher KE; Koscik RL; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Sager MA; Asthana S; Johnson SC; Benca RM; Bendlin BB
    Neurology; 2017 Aug; 89(5):445-453. PubMed ID: 28679595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk Cohort.
    Law LL; Sprecher KE; Dougherty RJ; Edwards DF; Koscik RL; Gallagher CL; Carlsson CM; Zetterberg H; Blennow K; Asthana S; Sager MA; Hermann BP; Johnson SC; Cook DB; Bendlin BB; Okonkwo OC
    J Alzheimers Dis; 2019; 69(1):111-121. PubMed ID: 30958346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.
    Hoscheidt SM; Starks EJ; Oh JM; Zetterberg H; Blennow K; Krause RA; Gleason CE; Puglielli L; Atwood CS; Carlsson CM; Asthana S; Johnson SC; Bendlin BB
    J Alzheimers Dis; 2016 Apr; 52(4):1373-83. PubMed ID: 27079723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.
    Osorio RS; Ayappa I; Mantua J; Gumb T; Varga A; Mooney AM; Burschtin OE; Taxin Z; During E; Spector N; Biagioni M; Pirraglia E; Lau H; Zetterberg H; Blennow K; Lu SE; Mosconi L; Glodzik L; Rapoport DM; de Leon MJ
    Neurobiol Aging; 2014 Jun; 35(6):1318-24. PubMed ID: 24439479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds.
    Skoog I; Kern S; Najar J; Guerreiro R; Bras J; Waern M; Zetterberg H; Blennow K; Zettergren A
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):983-990. PubMed ID: 33512503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
    Hansson O; Zetterberg H; Buchhave P; Londos E; Blennow K; Minthon L
    Lancet Neurol; 2006 Mar; 5(3):228-34. PubMed ID: 16488378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia.
    Chen DW; Wang J; Zhang LL; Wang YJ; Gao CY
    J Alzheimers Dis; 2018; 61(2):645-651. PubMed ID: 29278891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease.
    Eruysal E; Ravdin L; Zhang C; Kamel H; Iadecola C; Ishii M
    J Alzheimers Dis; 2023; 91(3):1073-1083. PubMed ID: 36565112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    Ma YH; Wu JH; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Feng L; Tan L; Yu JT
    J Alzheimers Dis; 2020; 77(1):411-421. PubMed ID: 32804140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
    Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C
    J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease.
    Lim B; Fowler C; Li QX; Rowe C; Dhiman K; Gupta VB; Masters CL; Doecke JD; Martins RN; Collins S; Diamandis EP
    Neurosci Lett; 2020 Jul; 731():135078. PubMed ID: 32450185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute sleep loss decreases CSF-to-blood clearance of Alzheimer's disease biomarkers.
    Liu H; Barthélemy NR; Ovod V; Bollinger JG; He Y; Chahin SL; Androff B; Bateman RJ; Lucey BP
    Alzheimers Dement; 2023 Jul; 19(7):3055-3064. PubMed ID: 36695437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance of Alzheimer's Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Vanninen A; Tesseur I; Pemberton D; Van Der Ark P; Kokkola T; Herukka SK; Rauramaa T; Hiltunen M; Blennow K; Zetterberg H; Leinonen V
    J Alzheimers Dis; 2023; 91(1):305-319. PubMed ID: 36404546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
    J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
    Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T
    J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dynamics of plasma biomarkers across the Alzheimer's continuum.
    Guo Y; Shen XN; Wang HF; Chen SD; Zhang YR; Chen SF; Cui M; Cheng W; Dong Q; Ma T; Yu JT
    Alzheimers Res Ther; 2023 Feb; 15(1):31. PubMed ID: 36750875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.